of Cairo, Egypt presented the factors that should be considered before performing a CTO procedure. First, it is essential to select the right patient, keeping in mind that the expected benefit of a CTO procedure must exceed the negative consequences. It is also important to take the age of the patient into account, as well to assess the level of anti-ischaemic medical therapy received, the symptom status and the ischaemic burden. According to current guidelines, percutaneous recanalization of CTOs should be considered in patients with expected ischaemia reduction in a corresponding myocardial territory and/or angina relief. 1 In addition, retrograde recanalisation of CTOs may be considered after a failed antegrade approach or as the primary approach in selected patients. In a meta-analysis comparing successful and failed PCI for CTO, successful PCI recanalisation of a CTO was associated with improved long-term clinical outcomes. 2 In another meta-analysis, successful recanalisation was associated with a significant reduction in the rate of residual/recurrent angina. 3 Good preparation is essential for performing CTO procedures. Preprocedural imaging should include myocardial perfusion imaging to assess ischaemia and myocardial viability, and multiple detector computed tomography to determine the 3D vessel course in the occluded segment, the length and composition of the CTO, and the distal vessel size and remodelling. Pre-procedural medications should comprise standard dual antiplatelet (DAPT) and anti-ischaemic therapy. Strategies to prevent contrast-induced nephropathy should also be considered; these include discontinuing any nephrotoxic drugs, intravascular volume expansion and administering a predefined maximum radiographic contrast dose (4 ml x body weight [kg]/serum creatinine [mg/dl]).
How to Ensure Procedural Safety and Good Long-term Results in Complex Coronary CTO Procedures
Radiation dose management is essential as radiation injury can lead to severe consequences for the patient, ranging from erythema that resolves in hours to ulceration that can take >6 weeks to heal; therefore, the patient should not undergo a repeat procedure prematurely.
It is also important to tailor the case selection to the level of experience European CTO registry shows the correlation between success rate and case load in performing PCI for CTOs (see Figure 1 ; http://www.ercto.org/).
Another essential factor in assuring success with CTO procedures is the use of the appropriate approach. A bilateral femoral approach gives a larger lumen for more equipment and better support, but has a higher rate of vascular complications. A bilateral radial approach results in a smaller lumen, less support, higher radiation exposure, but has a lower rate of vascular complications and better patient comfort.
A combined femoral and radial procedure is the optimal approach, using a larger sheath/guide than when using an antegrade approach.
It is essential to exert minimal disruption during the PCI procedure.
A study assessing the incidence of reocclusion and identification of predictors of angiographic failure after successful CTO, found that a successful subintimal tracking and re-entry technique was associated with a 57 % reocclusion rate. 5 However, the use of everolimus-eluting stents was associated with a significantly lower reocclusion rate.
The immediate outcome should be optimised -a final thrombolysis in myocardial infarction flow < grade 3 (TIMI <III) is associated with lower major adverse cardiac event-free survival rate. 6 In conclusion, appropriate pre-procedural planning is key to ensuring high success rates and avoiding unnecessary risk. Optimising the immediate outcome is essential to maintaining long-term patency.
This may be facilitated by minimal vessel disruption, and the use of IVUS and second-generation DES. Currently available DES with absorbable polymer may further improve device safety and efficacy. n
Live Case Demonstration
In order to illustrate the points discussed, a live case was presented from the Institut Cardiovasculaire Paris Sud, Massy, France. The Little ischaemia was evident but a proximal LAD occlusion was seen.
The Gaia guidewire was rotated rather than pushed into the cap. The proximal section was relatively easy to cross but the distal section was more difficult. The wire was withdrawn and re-entry attempted but it was not possible to cross the lesion with a microcatheter. To stabilise the catheter, trapping with a balloon was considered the safest approach. At the second attempt, the wire still did not move freely but managed to cross the occlusion. However, difficulty was encountered in crossing the occlusion with a balloon. An anchoring technique was then used to support the guide. The guidewire was changed and a subsequent predilation with a 2.0 balloon proved easier. However, the lesion was so calcified that the predilation was not fully successful, therefore a 2.5 balloon was used, up to Figure 2 ), thin stent struts (a total strut thickness of 88 μm, lower than other currently available DES) and an optimised delivery system. Next, Dr Garbo considered stent matching to the vessel.
The Coracto DES also features optimised geometry in its expanded state, a result of its sinusoidal link shape. Another important consideration is elastic recoil, i.e. the natural reduction in diameter of the stent after deflation of the balloon due to the elasticity of the stent material. Most DES are formed of cobalt-chromium, which has an average recoil of 5-6 %. The Coracto DES is made of stainless steel, which has an average recoil of only 2-3 %. 11 Stent recoil has been identified as a significant predictor of late lumen loss (LLL). 12 Longitudinal stent deformation is also a crucial factor in matching a stent to a vessel. The sinusoidal shape of the links in the Coracto stent minimises longitudinal deformation. The stent has a maximum expanded cell diameter of 4.0 mm, making it ideal for side-branch crossing. 11 Finally, the Coracto DES is designed to optimise clinical outcomes. Preclinical studies indicated that the polymer of the Coracto DES provides controlled release of rapamycin (sirolimus), and degradation of the polymer is completed within 8-10 weeks, leaving a BMS (see Figure 3 ). 13 Dr Garbo presented a case of a 75-year-old man with effort angina and moderate antero-lateral ischaemia identified by single-photon emission computerised tomography. A basal angiogram showed LAD ostial occlusion with some collateral flow from the right. The blunt CTO segment and occlusion length of >20 mm resulted in a J-CTO score of 2, which indicates a difficult procedure with reduced success rate (<90 %). 14 Finally, stent conformability is essential in homogeneous diffusion of the anti-proliferative drugs in the coronary vessels.
In conclusion, the Coracto DES is a safe and effective option in PCI of complex coronary anatomy cases with high procedural success rates and long-term beneficial effects. n
Summary and Concluding Remarks
These presentations have highlighted some important unmet needs in PCI interventions. In complex clinical cases such as CTO and full-metal jacket procedures, the Coracto stent's unique structure and rapid polymer absorption offers excellent conformability, efficacy and safety. n
